Insulet EPS - Earnings per Share 2010-2025 | PODD

Insulet earnings per share (EPS) for the twelve months ending March 31, 2025 was $5.55, a 66.67% increase year-over-year.

  • Insulet EPS for the quarter ending March 31, 2025 was $0.50, a 31.51% decline year-over-year.
  • Insulet 2024 annual EPS was $5.78, a 96.6% increase from 2023.
  • Insulet 2023 annual EPS was $2.94, a 4100% increase from 2022.
  • Insulet 2022 annual EPS was $0.07, a 70.83% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Insulet EPS - Earnings per Share 2010-2025 | PODD

  • Insulet EPS for the quarter ending March 31, 2025 was $0.50, a 31.51% decline year-over-year.
  • Insulet 2024 annual EPS was $5.78, a 96.6% increase from 2023.
  • Insulet 2023 annual EPS was $2.94, a 4100% increase from 2022.
  • Insulet 2022 annual EPS was $0.07, a 70.83% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$229.2B
Boston Scientific (BSX)$152.7B
Stryker (SYK)$149.2B
EssilorLuxottica (ESLOY)$131.9B
Medtronic (MDT)$115.1B
Lonza Group Ag (LZAGY)$50.1B
Haleon (HLN)$43.5B
ResMed (RMD)$37.3B
GE HealthCare Technologies (GEHC)$34.5B
Agilent Technologies (A)$32.2B
Terumo (TRUMY)$24.4B
Koninklijke Philips (PHG)$23.5B
Zimmer Biomet Holdings (ZBH)$18.6B
Baxter (BAX)$14.6B
Smith & Nephew SNATS (SNN)$13B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Bio-Rad Laboratories (BIO)$6.7B
Lantheus Holdings (LNTH)$5.1B
Perrigo (PRGO)$3.7B
Prestige Consumer Healthcare (PBH)$3.7B
Haemonetics (HAE)$3.6B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.3B
ICU Medical (ICUI)$3.1B
LeMaitre Vascular (LMAT)$1.9B
QuidelOrtho (QDEL)$1.9B
AtriCure (ATRC)$1.5B
Acuren (TIC)$1.4B
Phibro Animal Health (PAHC)$1.2B